TB

How most vital TB drug attacks its target revealed

How most vital TB drug attacks its target revealedWashington, Aug 14 - A new study has provided a better insight into the mechanism behind the key medication of tuberculosis (TB) attacking the dormant TB bacteria in order to shorten treatment.


WHO says dip in stocks of TB drugs in India

WHO says dip in stocks of TB drugs in India June 21 : The World Health Organisation (WHO) Friday said there was a dip in the buffers stock of anti-tuberculosis (TB) drugs in India, but this would in no way affect treatment of patients.

"There is a dip in the buffer stock of anti-TB drugs. We understand that the government of India has initiated steps to ensure replenishment," Nata Menabde, WHO representative to India, said in a statement here.


Low-cost pain killer can wipe out resistant TB, say researchers

Low-cost pain killer can wipe out resistant TB, say researchersWashington, Sep 13 - A low-cost drug, which is widely used as a pain killer in developing countries, can kill drug-resistant tuberculosis (TB) -- a feat few currently approved TB drugs can accomplish, say researchers.

Weill Cornell Medical College researchers point to a potential new therapy for the more than half million people worldwide whose TB has become resistant to standard drug treatments.


Speedy drug metabolism makes some TB patients resistant to treatment

 Speedy drug metabolism makes some TB patients resistant to treatmentWashington, Dec 29 : Scientists including one of an Indian origin have found that multidrug-resistant tuberculosis (TB) is more likely caused in patients by speedy drug metabolism rather than inconsistent doses, as is widely believed.

The finding may lead to better ways to treat one of the world's major infectious diseases.


Scientists envisage vaccines for malaria, TB, HIV/AIDS by 2020

 Scientists envisage vaccines for malaria, TB, HIV/AIDS by 2020 London, May 26 : Scientists have shared insight into rational vaccine development, and envisage that by 2020 there would be vaccines for malaria, TB, and HIV/AIDS.

Seattle BioMed Director Alan Aderem, Ph. D., along with Rino Rappuoli, Ph. D., Global Head of Vaccines Research for Novartis Vaccines and Diagnostics, discussed recent advances in vaccine development.


New research to identify antibiotics that may help fight TB

New research to identify antibiotics that may help fight TBWashington, March 12: A new international research is being carried out by scientists to identify antibiotics that can kill tuberculosis and fight resistant strains.

"We want to accelerate the discovery of new compounds that can be turned into effective drugs," said Professor Tony Maxwell from the John Innes Centre, a key player in "More Medicines for Tuberculosis", a new European research project.


Germans test first new TB vaccine for 80 years

Germans test first new TB vaccine for 80 years BerlinĀ  - Amid worldwide fears that tuberculosis is adapting to thwart existing drugs, Germany began human testing this week of what is described as the first new live vaccine against tuberculosis for more than 80 years.

The drug, named VPM1002, is a genetic refinement of the Bacille Calmette-Guerin (BCG) vaccine that has been used to immunize hundreds of millions of people since 1921.


Two global TB initiatives to be announced on Monday

TBGeneva, June 26 : Two major health initiatives that will have a substantial impact in the fight against the global tuberculosis (TB) epidemic will be announced on Monday.

A joint announcement will be made by FIND, the Stop TB Partnership, UNITAID and WHO.


Syndicate content